Overview

GnRH Agonist and Antagonists in an Oocyte Donation Program

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
Female
Summary
The primary purpose of this study is to evaluate the effect of the two different protocols (long protocol vs antagonist protocol) on oocyte / embryo quality.
Phase:
Phase 4
Details
Lead Sponsor:
Instituto Valenciano de Infertilidad, IVI VALENCIA
Treatments:
Cetrorelix
Leuprolide
Criteria
Inclusion Criteria:

- oocyte donors with age range: 18 - 34; BMI: 18 - 29 kg/m2;

Exclusion Criteria:

- PCO